HIGHLIGHTS
- who: Flavia Linguanti and collaborators from the University of Florence, Florence, Italy have published the article: Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy, in the Journal: Cancers 2022, 14, 4700. of 27/09/2022
SUMMARY
Chimeric antigen receptor-engineered (CAR) T_cells represent a new powerful tool for the treatment of refractory hematologic malignancies. The therapy is based on the genetic modification of patient-derived T_cells by means of viral_vectors enabling artificial chimeric antigen receptors expression to recognize specific tumor-associated antigens. The antigen CD19 is widely expressed on B . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.